Ensuring our customers, public authorities, health professionals, and above all, patients have access to innovation.

We seek excellence in the field of home respiratory therapy, by improving the care and wellbeing of patients, based on innovation and maintaining the highest ethical standards and quality.

We have a large team of healthcare professionals with proven experience who are specifically trained to offer personalised attention to each patient who comes to us and to whom we furthermore guarantee access to the most cutting-edge equipment. And all this with one goal: to improve the wellbeing and quality of life of patients.

EsteveTeijin Healthcare is the result of the strategic alliance between the chemical/pharmaceutical group ESTEVE and TEIJIN PHARMAharma, which has the goal of becoming a company active in Europe, focused on innovation and dedicated to providing the highest quality service to home respiratory therapy patients.


PATIENTS ASSOCIATIONS:

• British Lung Foundation: www.lunguk.org

ESTEVE is a domestically-owned chemical/pharmaceutical group with a strong international presence. It operates in the pharmaceutical area through the research and development of new drugs and marketing a broad portfolio of prescription products, public medicinal products, vaccines, generic drugs and products for veterinary use. It is also present in the chemical field through developing, manufacturing and marketing pharmaceutical active ingredients; thus offering a global solution in the healthcare field.

ESTEVE is a company that is characterised by its clear focus on innovation, by its commitment to the patient and health professionals, and has a mission of bringing value to society through new therapies. For years ESTEVE has had a major presence in the pulmonology field, offering high added value, not just through its products but also through a clear commitment to training through courses and symposia.

www.esteve.com

TEIJIN is a leading group in Japan, active in several areas, including marketing pharmaceutical products and home respiratory treatment services. Specifically in this latter field, TEIJIN is a leader in innovation, through developing oxygen concentrators, equipment for improved diagnosis of the sleep apnea and patient care services, among other things.

It is currently a leader in providing home respiratory therapy services in Japan and continues to work on improving the quality of life of patients living at home.

www.teijin-pharma.co.jp

PRESS RELEASES:

    We will soon add the materials.